Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report

Neuroleptic malignant syndrome is a neurological emergency caused by dysregulation of dopaminergic neurotransmission. While it is typically characterized by muscle rigidity, fever and altered mental status, it may have a heterogeneous and non-specific presentation, leading to delays in diagnosis an...

Full description

Bibliographic Details
Main Authors: Ana Maia, Gonçalo Cotovio, Bernardo Barahona-Corrêa, Albino J. Oliveira-Maia
Format: Article
Language:English
Published: Ordem dos Médicos 2021-06-01
Series:Acta Médica Portuguesa
Subjects:
Online Access:https://actamedicaportuguesa.com/revista/index.php/amp/article/view/13019
_version_ 1798028230808043520
author Ana Maia
Gonçalo Cotovio
Bernardo Barahona-Corrêa
Albino J. Oliveira-Maia
author_facet Ana Maia
Gonçalo Cotovio
Bernardo Barahona-Corrêa
Albino J. Oliveira-Maia
author_sort Ana Maia
collection DOAJ
description Neuroleptic malignant syndrome is a neurological emergency caused by dysregulation of dopaminergic neurotransmission. While it is typically characterized by muscle rigidity, fever and altered mental status, it may have a heterogeneous and non-specific presentation, leading to delays in diagnosis and treatment. Treatment involves cessation of dopamine-receptor antagonists and supportive measures, but in more severe cases, bromocriptine, dantrolene, benzodiazepines and/or electroconvulsive therapy should be considered. We present the case of a 66-year-old man with severe neuroleptic malignant syndrome, diagnosed due to need for continuous invasive ventilation in an Intensive Care Unit, after successful treatment for respiratory sepsis. The patient recovered after electroconvulsive therapy and administration of bromocriptine. This unusually severe case illustrates the need for a high level of suspicion for neuroleptic malignant syndrome in critically ill patients with malignant catatonic syndromes, allowing for an early diagnosis and potentially lifesaving treatment.
first_indexed 2024-04-11T19:04:35Z
format Article
id doaj.art-d2df2e024b134eb3a238843bb96ccb6a
institution Directory Open Access Journal
issn 0870-399X
1646-0758
language English
last_indexed 2024-04-11T19:04:35Z
publishDate 2021-06-01
publisher Ordem dos Médicos
record_format Article
series Acta Médica Portuguesa
spelling doaj.art-d2df2e024b134eb3a238843bb96ccb6a2022-12-22T04:07:50ZengOrdem dos MédicosActa Médica Portuguesa0870-399X1646-07582021-06-0134610.20344/amp.130195115Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case ReportAna Maia0Gonçalo Cotovio1Bernardo Barahona-Corrêa2Albino J. Oliveira-Maia3Departament of Psychiatry and Mental Health. Hospital Egas Moniz. Centro Hospitalar de Lisboa Ocidental. Lisboa. NOVA Medical School | Faculdade de Ciências Médicas. Universidade NOVA de Lisboa. Lisboa. Champalimaud Research and Clinical Centre. Champalimaud Centre for the Unknown. Lisboa. b. NOVA Medical School | Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal c. Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unkown, Av. Brasilia 1400-038, Lisboa, PortugalDepartament of Psychiatry and Mental Health. Hospital Egas Moniz. Centro Hospitalar de Lisboa Ocidental. Lisboa. NOVA Medical School | Faculdade de Ciências Médicas. Universidade NOVA de Lisboa. Lisboa. Champalimaud Research and Clinical Centre. Champalimaud Centre for the Unknown. Lisboa. b. NOVA Medical School | Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal c. Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unkown, Av. Brasilia 1400-038, Lisboa, PortugalDepartament of Psychiatry and Mental Health. Hospital Egas Moniz. Centro Hospitalar de Lisboa Ocidental. Lisboa. NOVA Medical School | Faculdade de Ciências Médicas. Universidade NOVA de Lisboa. Lisboa. Champalimaud Research and Clinical Centre. Champalimaud Centre for the Unknown. Lisboa. b. NOVA Medical School | Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal c. Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unkown, Av. Brasilia 1400-038, Lisboa, PortugalDepartament of Psychiatry and Mental Health. Hospital Egas Moniz. Centro Hospitalar de Lisboa Ocidental. Lisboa. NOVA Medical School | Faculdade de Ciências Médicas. Universidade NOVA de Lisboa. Lisboa. Champalimaud Research and Clinical Centre. Champalimaud Centre for the Unknown. Lisboa. b. NOVA Medical School | Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal c. Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unkown, Av. Brasilia 1400-038, Lisboa, Portugal Neuroleptic malignant syndrome is a neurological emergency caused by dysregulation of dopaminergic neurotransmission. While it is typically characterized by muscle rigidity, fever and altered mental status, it may have a heterogeneous and non-specific presentation, leading to delays in diagnosis and treatment. Treatment involves cessation of dopamine-receptor antagonists and supportive measures, but in more severe cases, bromocriptine, dantrolene, benzodiazepines and/or electroconvulsive therapy should be considered. We present the case of a 66-year-old man with severe neuroleptic malignant syndrome, diagnosed due to need for continuous invasive ventilation in an Intensive Care Unit, after successful treatment for respiratory sepsis. The patient recovered after electroconvulsive therapy and administration of bromocriptine. This unusually severe case illustrates the need for a high level of suspicion for neuroleptic malignant syndrome in critically ill patients with malignant catatonic syndromes, allowing for an early diagnosis and potentially lifesaving treatment. https://actamedicaportuguesa.com/revista/index.php/amp/article/view/13019Intensive Care UnitsNeuroleptic Malignant Syndrome/diagnosisNeuroleptic Malignant Syndrome/therapy
spellingShingle Ana Maia
Gonçalo Cotovio
Bernardo Barahona-Corrêa
Albino J. Oliveira-Maia
Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
Acta Médica Portuguesa
Intensive Care Units
Neuroleptic Malignant Syndrome/diagnosis
Neuroleptic Malignant Syndrome/therapy
title Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
title_full Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
title_fullStr Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
title_full_unstemmed Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
title_short Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
title_sort diagnosis and treatment of neuroleptic malignant syndrome in the intensive care unit a case report
topic Intensive Care Units
Neuroleptic Malignant Syndrome/diagnosis
Neuroleptic Malignant Syndrome/therapy
url https://actamedicaportuguesa.com/revista/index.php/amp/article/view/13019
work_keys_str_mv AT anamaia diagnosisandtreatmentofneurolepticmalignantsyndromeintheintensivecareunitacasereport
AT goncalocotovio diagnosisandtreatmentofneurolepticmalignantsyndromeintheintensivecareunitacasereport
AT bernardobarahonacorrea diagnosisandtreatmentofneurolepticmalignantsyndromeintheintensivecareunitacasereport
AT albinojoliveiramaia diagnosisandtreatmentofneurolepticmalignantsyndromeintheintensivecareunitacasereport